Kura Oncology KURA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's deferred tax assets and other non-current assets?
- Kura Oncology (KURA) reported deferred tax assets and other non-current assets of $13.99M in Q1 2026.
- How has Kura Oncology's deferred tax assets and other non-current assets changed year-over-year?
- Kura Oncology's deferred tax assets and other non-current assets increased by 54.1% year-over-year, from $9.08M to $13.99M.
- What is the long-term trend for Kura Oncology's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Kura Oncology's deferred tax assets and other non-current assets has grown at a 60.7% compound annual growth rate (CAGR), from $1.36M to $14.54M.